Wockhardt, RDIF to produce Sputnik V, Sputnik Light COVID-19 vaccines
Category: #health  | By Mateen Dalal  | Date: 2021-11-09 |
  • shareshare_icon
  • Twitter
  • Facebook
  • LinkedIn

Wockhardt, RDIF to produce Sputnik V, Sputnik Light COVID-19 vaccines

Pharmaceutical firm, Wockhardt has recently announced that it has teamed with the Russian Direct Investment Fund (RDIF) to produce and supply COVID-19 vaccines Sputnik V and Sputnik Light. ENSO Healthcare, RDIF's coordination partner for supplying Sputnikin vaccine in India, drafted the deal.

Sputnik V, based on human adenoviral vectors, uses two distinct vectors for each of the two doses in a course. Component-1 of the Russian vaccination Sputnik V is the same as Sputnik Light.

Wockhardt mentioned that the single-dose Sputnik Light shot showcased 79.4% efficacy according to assessed data obtained from 28 days after the vaccine was administered as part of a mass vaccination program in Russia.

While RDIF stated that Sputnik Light demonstrated 70% efficiency against the Delta variant of the virus in the first three months following immunization.

Although Sputnik V received permission from India's drug regulator in April and is used as a part of a nationwide COVID-19 vaccination drive, Sputnik Light has yet to acquire approval.

RDIF is working with several Indian pharmaceutical businesses to increase the production of the Sputnik vaccine in India, which will be used in both domestic and international markets.

Dr. Reddy's Laboratory Limited received authorization from the Drugs Controller General of India (DCGI) to undertake Phase-3 bridging trials of Sputnik Light in India in September.

The DCGI granted permission based on the recommendations of the Central Drugs Standard Control Organization’s (CDSCO) Subject Expert Committee on COVID-19, which held a meeting on 5th August.

In a similar instance, Prestige Biopharma recently revealed that it signed a technology transfer contract with RDIF subsidiary Human Vaccine (HV) and ENSO to produce the Sputnik Light COVID-19 vaccine.

The firm expects to secure a vaccine production capacity of 104,000 liters by constructing the annex building and the Prestige Biopharma Vaccine Center and assigning a portion of its capacity to the contract manufacture of Sputnik Light.

Source Credit-

https://www.businesstoday.in/coronavirus/story/wockhardt-partners-with-rdif-to-produce-sputnik-v-sputnik-light-covid-19-vaccines-311575-2021-11-08

  • shareshare_icon
  • Twitter
  • Facebook
  • LinkedIn


About Author

Mateen Dalal     twitter

Mateen Dalal

A qualified electronics and telecommunication engineer, Mateen Dalal embarked on his professional journey working as a quality and test engineer. Harnessing his passion for content creation however, Mateen pens down industry-rich articles for ReportsGO.com and a few o...

Read More..

More News By Mateen Dalal

Microsoft investigates Teams and Outlook outage that left users disrupted

Microsoft investigates Teams and Outlook outage that left users disrupted

By Mateen Dalal

Microsoft, the U.S.-based technology frontrunner, reportedly investigating an outage that prevented thousands of customers from accessing services like Teams and Outlook. Apparently, the tech giant did not disclose the number of users that were im...

UK: Budget & basic items’ cost in supermarkets soar 20.3% in December

UK: Budget & basic items’ cost in supermarkets soar 20.3% in December

By Mateen Dalal

Britishers who rely on the budget-friendly aisles of supermarkets reportedly saw the biggest increases in food prices in the months leading up to Christmas, significantly outpacing those for luxury as well as premium brands, as per a survey. Accor...

Sun Cable shuts as $21B solar project to power S’pore hangs in balance

Sun Cable shuts as $21B solar project to power S’pore hangs in balance

By Mateen Dalal

Sun Cable, the Singapore-based solar energy company, has reportedly entered voluntary administration, despite the financial support it received from billionaire investors. The company was supposed to be working on a A$30 billion (US$21 billion) solar...